China/Philippines: Antitrust regulators to strengthen competition law enforcement

The Philippine Competition Commission (PCC) has signed a memorandum of understanding with China’s State Administration for Market Regulation (SAMR) to strengthen both countries’ bilateral cooperation on competition law enforcement.
The accord was signed in Manila on Tuesday, November 19, the PCC said in a statement on Wednesday. PCC Chairman Arsenio Balisacan and SAMR Minister Xiao Yaqing led the signing ceremony.
Both antitrust authorities agreed to lay down a general framework for cooperation in competition enforcement, including exchange of information, coordination of enforcement activities, notification of cases of mutual interest, as well as technical cooperation and capacity building.
“Our MoU marks the start of a productive partnership between the PCC and SAMR, recognizing that international cooperation is essential to safeguard competition in today’s increasingly borderless and dynamic markets,” Balisacan said.
The move is part of PCC’s strategy to work closely with international counterparts, including an active engagement with the ASEAN Experts Group on Competition, the International Competition Network (ICN), the United Nations Conference on Trade and Development (UNCTAD), and the Organisation for Economic Co-operation and Development (OECD) Competition Division.
Full Content: GMA Network
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas